香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內 容 概 不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不對因本公告全部或任何部分內容而產生或因倚賴該等內容而引致的 任 何 損 失 承 擔 任 何 責 任。 中國太平洋保險（集團）股份有限公司 CHINA PACIFIC INSURANCE (GROUP) CO., LTD. （於中華人民共和國註冊成立的股份有限公司） （股份代號：02601） 海外監管公告 本 海 外 監 管 公 告 乃 按 香 港 聯 合 交 易 所 有 限 公 司 證 券 上 市 規 則（「上市規則」） 第13.09條、第13.10B條及香港法例第571章《證 券 及 期 貨 條 例》第XIVA部 下 之 內 幕 消 息 條 文（定 義 見 上 市 規 則）之 規 定 作 出。 茲 載 列 該 公 告 如 下，僅 供 參 考。 承董事會命 | 公司名稱： | 中國太平洋人壽保險股份有限公司 | | --- | --- | | 公司英文名稱： | China Pacific Life Insurance Co., Ltd ...

Core Viewpoint - China Life Insurance Company Limited is establishing a partnership with China Nuclear Power and the China-Russia Nuclear Industry Fund to create a partnership enterprise with a total capital contribution of RMB 1.501 billion, where China Life will contribute RMB 1.2 billion [2][3][7]. Group 1: Partnership Agreement - The partnership will include China Life Insurance, China Nuclear Power, and the China-Russia Nuclear Industry Fund as limited partners, while Guangzhou Jinhong and the China Nuclear Fund will act as general partners [3][6]. - The total capital contribution from all partners is RMB 1,501,000,000, with specific contributions detailed as follows: - Guangzhou Jinhong: RMB 1,000,000 - China Nuclear Fund: RMB 1,000,000 - China Life: RMB 1,200,000,000 - China Nuclear Power: RMB 279,000,000 - China-Russia Nuclear Industry Fund: RMB 20,000,000 [3][4]. Group 2: Investment Strategy - The partnership enterprise aims to invest in domestic nuclear power companies involved in the development, investment, construction, and operation of nuclear power projects, contributing to China's clean and low-carbon energy development [5][6]. - The investment period for the partnership is set for six years, followed by a four-year exit period, with the possibility of extending the duration if necessary [5]. Group 3: Management and Fees - Guoshou Jingshi will serve as the manager of the partnership, providing daily operational and investment management services, with an annual management fee of 0.1% of the total capital contributions [6][8]. - An investment decision committee will be established to oversee investment and exit decisions, while an investment advisory committee will evaluate potential conflicts of interest and compliance with regulations [6][7]. Group 4: Rationale for the Transaction - The investment in nuclear assets is expected to provide long-term, stable dividend returns, aligning with the company's strategy to enhance long-term investment returns and support green finance initiatives [7][8]. - The transaction is deemed fair and reasonable, conducted under normal commercial terms, and is in the overall interest of the company and its shareholders [7].